Gabapentin and Opioid Co-Exposure During Pregnancy and Adverse Perinatal Outcomes: A Population-Based Study, 2020–2024

These findings highlight the pattern of gabapentin use during pregnancy, including frequent co-use with opioids. Due to data limitations, causal inferences cannot be drawn. Further research with detailed exposure information and maternal comorbidities is needed to clarify risks and inform clinical care and long-term outcomes.